Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors

  • Jennifer Kleponis
  • , Richard Skelton
  • , Lei Zheng

Producción científica: Review article › revisión exhaustiva

Resumen

Immune checkpoint inhibitors are increasingly drawing much attention in the therapeutic development for cancer treatment. However, many cancer patients do not respond to treatments with immune checkpoint inhibitors, partly because of the lack of tumor-infiltrating effector T cells. Cancer vaccines may prime patients for treatments with immune checkpoint inhibitors by inducing effector T-cell infiltration into the tumors and immune checkpoint signals. The combination of cancer vaccine and an immune checkpoint inhibitor may function synergistically to induce more effective antitumor immune responses, and clinical trials to test the combination are currently ongoing.

Idioma originalEnglish (US)
Páginas (desde-hasta)201-208
Número de páginas8
PublicaciónCancer Biology and Medicine
Volumen12
N.º3
DOI
EstadoPublished - sept 1 2015
Publicado de forma externaSí

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Huella

Profundice en los temas de investigación de 'Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors'. En conjunto forman una huella única.

Citar esto